According to Coherent Market Insights, the global vitamin API market is expected to reach $724.2 million by 2031 at a CAGR of 6.1%

BURLINGAME, May 14, 2024 (Globe Newswire) — global vitamin drug substance market The value in 2023 is estimated at USD 451.1 million and is expected to exhibit a CAGR of 6.1% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights . Vitamin API refers to active pharmaceutical ingredients used in the production of dietary supplements and pharmaceutical formulations. Vitamin API helps improve immunity and overall health.

Get a sample page: https://www.coherentmarketinsights.com/insight/request-sample/6678

Market dynamics:

The global vitamin API market is driven by increasing demand for dietary supplements as consumers become more aware of the importance of vitamins for overall health and wellness. Additionally, the prevalence of vitamin deficiencies in the world’s population is also increasing the demand for vitamin APIs. Furthermore, increasing global geriatric population and increasing focus on preventive healthcare are expected to drive market growth in the coming years.

Scope of the Global Vitamin API Market Report

Market trend:

One of the key trends in the global vitamin API market is the growing popularity of personalized nutrition, where consumers are seeking customized vitamin formulations based on their personal health needs and goals. This trend is driving innovation in the market, with companies developing new vitamin API products to meet this demand. Another trend is the increasing adoption of clean label and natural vitamin APIs as consumers prefer products free of artificial additives and chemicals. As a result, manufacturers are focusing on developing vitamin APIs sourced from natural ingredients to meet this growing demand.

market opportunity:

The global vitamin API market is expected to witness significant growth due to increasing demand for vitamin APIs in the pharmaceutical industry. Vitamin APIs play an important role in the production of a variety of pharmaceutical products, including vitamin and mineral supplements essential to maintaining good health. Owing to the increasing incidence of chronic diseases and growing awareness about the importance of vitamins in disease prevention, the demand for vitamin APIs is expected to increase steadily during the forecast period.

story continues

Customize this report by 10%: https://www.coherentmarketinsights.com/insight/request-customization/6678

Another major market opportunity for the global vitamin API market is the growing trend of personalized nutrition. Demand for custom-made supplements containing vitamin APIs is increasing as consumers become more health conscious and seek personalized solutions to meet their specific nutritional needs. Personalized nutrition involves developing tailored products based on an individual’s unique dietary requirements, lifestyle, and health goals. This trend is driving innovation in the vitamin API market as manufacturers strive to develop formulations that meet the diverse needs of consumers.

Recent developments:

In October 2023, Guangdong Baida Biotechnology Co., Ltd. released poop candy containing nutritional ingredients such as vitamin C and bifidobacteria.

In September 2023, Vibrant Health launched Trilogy, a revolutionary 3-in-1 multi-supplement.

Key points in the market:

The global vitamin API market is anticipated to witness a CAGR of 6.1% during the forecast period 2024-2031 due to increasing demand for vitamin APIs in the pharmaceutical industry and growth trends in personalized nutrition.

Based on type, vitamin B1 segment is expected to maintain its dominant position due to its wide range of applications in the pharmaceutical industry.

On a regional basis, North America is expected to maintain its dominant position throughout the forecast period due to the presence of large pharmaceutical companies and increasing investments in research and development.

Some of the key players operating in the global vitamin API market include DSM, BASF, BOC Sciences, CSPC Pharmaceutical Group Limited, Lonza, Zhejiang Medicine, Jubilant Life Sciences, Glanbia Nutritionals, Aurorium, Northeast Pharmaceutical Group Co., Ltd, and Abbott Laboratories. , and Fermenta Biotech. These companies are focusing on product innovation and expanding their product portfolios to gain a competitive edge in the market.

Purchase this complete business research report: https://www.coherentmarketinsights.com/insight/buy-now/6678

Detailed segmentation:

By type:

• Vitamin B1

• vitamin B6

• vitamin B12

• vitamin B2

• vitamin B3

• vitamin B5

• vitamin B7

• vitamin B9

• vitamin C

• vitamin D

• vitamin E

• vitamin A

• vitamin K

By category:

• impurities

• Pharmaceutical standards

By purity:

By manufacturing type:

According to standard:

By grade:

• pharmaceutical grade

• food grade

• animal feed grade

• others

By end user:

By region:

• North America

• latin america

  • Brazil

  • Mexico

  • Rest of Latin America

• Europe

  • Germany

  • England

  • Spain

  • France

  • Italy

  • Russia

  • rest of europe

• Asia Pacific

  • China

  • India

  • Japan

  • Australia

  • South Korea

  • Rest of Asia Pacific

• middle east and africa

Related reports:

Intravenous (IV) Ibuprofen Market, By Indication (Pain Management, Fever, Others), Strength (100 mg, 200 mg, 400 mg, 800 mg), By Age Group (Pediatrics & Adults), By Distribution Channel (Hospitals) pharmacies, retail pharmacies, online pharmacies), by region (North America, Latin America, Europe, Asia Pacific, Middle East, Africa)

Hemostasis/Coagulation Analyzer Market, By Product (Clinical Laboratory Analyzers, Reagents, Systems, and Point-of-Care Test Analyzers), By Test (Prothrombin Time Test, Fibrinogen Test, Activated Clotting Time Test, Platelet Function Test, Factor

Tobramycin eye drops market, by type (tobramycin and dexamethasone suspension, tobramycin suspension, other tobramycin combinations), by indication (bacterial eye infections, keratitis, prophylaxis before and after eye surgery, others), distribution By Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Geography (North America, Latin America, Europe, Asia Pacific, Middle East, Africa)

Trenbolone Enanthate Market, By Type (Trenbolone Enanthate Powder and Trenbolone Enanthate Injection), By Application (Pharmaceuticals & Veterinary Medicines), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, Africa)

About us:

Coherent Market Insights is a global market intelligence and consulting organization providing syndicated research reports, customized research reports, and consulting services. We deliver actionable insights and authentic reports in a variety of domains, including Aerospace & Defense, Agriculture, Food & Beverages, Automotive, Chemicals & Materials, an exhaustive list of virtually all domains and subdomains. is known. We create value for our clients through reliable and accurate reporting. We are also committed to playing a leading role in providing insights in a variety of areas post-COVID-19 and continue to deliver measurable and sustainable outcomes for our clients.

Please follow us: linkedin | twitter

CONTACT: Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com